The Australian market has been experiencing mixed performance, with the ASX200 trading in the red as sectors like Industrials, Health Care, and Energy struggled while Real Estate and Discretionary showed resilience. In such a fluctuating environment, identifying undervalued stocks can be crucial for investors looking to capitalize on potential growth opportunities amidst broader market challenges. Top 10 Undervalued Stocks Based On Cash Flows In Australia Name Current Price Fair Value (Est) Discount (Est) Vysarn (ASX:VYS) A$0.51 A$0.99 48.5% Superloop (ASX:SLC) A$3.30 A$6.54 49.6% Reckon (ASX:RKN) A$0.63 A$1.19 46.9% PointsBet Holdings (ASX:PBH) A$1.21 A$2.13 43.2% Fenix Resources (ASX:FEX) A$0.295 A$0.51 42.1% Collins Foods (ASX:CKF) A$9.12 A$15.98 42.9% Charter Hall Group (ASX:CHC) A$21.17 A$36.21 41.5% Austal (ASX:ASB) A$7.20 A$13.15 45.3% Appen (ASX:APX) A$0.90 A$1.79 49.7% Advanced Braking Technology (ASX:ABV) A$0.092 A$0.16 44.2% Click here to see the full list of 34 stocks from our Undervalued ASX Stocks Based On Cash Flows screener. Let's review some notable picks from our screened stocks. Domino's Pizza Enterprises Overview: Domino's Pizza Enterprises Limited operates retail food outlets and has a market capitalization of A$1.78 billion. Operations: The company generates revenue of A$2.30 billion from its restaurant operations. Estimated Discount To Fair Value: 38% Domino's Pizza Enterprises is trading at A$18.82, significantly below its estimated fair value of A$30.35, suggesting it may be undervalued based on cash flows. Despite high debt levels and recent leadership changes, the company is expected to see significant annual earnings growth of 32.9%, outpacing the broader Australian market. However, profit margins have declined from last year and dividends are not well covered by earnings, indicating potential financial challenges ahead. The growth report we've compiled suggests that Domino's Pizza Enterprises' future prospects could be on the up. Click here to discover the nuances of Domino's Pizza Enterprises with our detailed financial health report.ASX:DMP Discounted Cash Flow as at Aug 2025 Genesis Minerals Overview: Genesis Minerals Limited is involved in the exploration, production, and development of gold deposits in Western Australia with a market cap of A$4.53 billion. Operations: The company generates revenue of A$561.40 million from its mineral production, exploration, and development activities in Western Australia. Estimated Discount To Fair Value: 27.4% Genesis Minerals, trading at A$4.01, appears undervalued with a fair value estimate of A$5.52 and is positioned for robust growth. The company's projected annual earnings growth of 25% surpasses the Australian market average, driven by expected revenue increases of 20.9% per year. Recent leadership changes include the appointment of Jane Macey as Non-Executive Director, bringing extensive industry expertise which could enhance strategic direction amid low forecasted return on equity in three years (18.7%). Story Continues Upon reviewing our latest growth report, Genesis Minerals' projected financial performance appears quite optimistic. Take a closer look at Genesis Minerals' balance sheet health here in our report.ASX:GMD Discounted Cash Flow as at Aug 2025 Regis Healthcare Overview: Regis Healthcare Limited provides residential aged care services in Australia and has a market cap of A$2.65 billion. Operations: The company's revenue is primarily derived from its residential aged care services, totaling A$1.10 billion. Estimated Discount To Fair Value: 30.1% Regis Healthcare, trading at A$8.8, is undervalued with a fair value estimate of A$12.59, offering potential for significant earnings growth of 24.4% annually over the next three years, outpacing the Australian market average. Despite becoming profitable this year and expected high return on equity (231.3%), challenges include negative shareholders' equity and recent insider selling activity which may warrant caution for investors assessing its cash flow valuation appeal. The analysis detailed in our Regis Healthcare growth report hints at robust future financial performance. Unlock comprehensive insights into our analysis of Regis Healthcare stock in this financial health report.ASX:REG Discounted Cash Flow as at Aug 2025 Key Takeaways Navigate through the entire inventory of 34 Undervalued ASX Stocks Based On Cash Flows here. Have a stake in these businesses? Integrate your holdings into Simply Wall St's portfolio for notifications and detailed stock reports. Discover a world of investment opportunities with Simply Wall St's free app and access unparalleled stock analysis across all markets. Curious About Other Options? Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include ASX:DMP ASX:GMD and ASX:REG. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email [email protected] View Comments
ASX Stocks Including Domino's Pizza Enterprises That Investors May Be Undervaluing
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research.
Start Your Free Trial Now!Not sure where to invest today?
Kalkine’s latest research highlights three companies identified through in-depth analysis and market insights.
Explore these research reports to learn about companies currently being tracked by our analysts and make more informed investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...